drugset / Trial / NCT05858047
An Investigational Study to Evaluate Experimental Medication SYHX1901 Tablets With Moderate to Severe Plaque Psoriasis
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to evaluate the efficacy and safety of different doses of SYHX1901 tablets in the treatment of moderate to severe plaque psoriasis in order to select doses for further clinical trials.
Timeline
- Start
- 2023-04-11
- Primary completion
- 2024-02-21
- Completion
- 2024-02-21
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | SYHX1901 | Unknown | 60 mg | Oral |
| Subject | SYHX1901 | Unknown | 90 mg | Oral |
| Subject | SYHX1901 | Unknown | 180 mg | Oral |
Indications
No indication recorded.